Timothy B. Saurer

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Google:
"Timothy Saurer"
Mean distance: 16440.9 (cluster 19)
 

Parents

Sign in to add mentor
Donald T. Lysle grad student 2007 UNC Chapel Hill
 (Neuroimmune mechanisms of opioid -mediated immunomodulation.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hutson LW, Szczytkowski JL, Saurer TB, et al. (2014) Region-specific contribution of the ventral tegmental area to heroin-induced conditioned immunomodulation. Brain, Behavior, and Immunity. 38: 118-24
Saurer TB, Ijames SG, Lysle DT. (2009) Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations. The Journal of Pharmacology and Experimental Therapeutics. 329: 1040-7
Saurer TB, Ijames SG, Carrigan KA, et al. (2008) Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation. Brain, Behavior, and Immunity. 22: 89-97
Saurer TB, Ijames SG, Lysle DT. (2006) Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. Journal of Neuroimmunology. 177: 18-26
Saurer TB, Carrigan KA, Ijames SG, et al. (2006) Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. Journal of Neuroimmunology. 173: 3-11
Saurer TB, Ijames SG, Lysle DT. (2006) Opioid-induced increases in nucleus accumbens dopamine may modulate immune status via the sympathetic nervous system Brain, Behavior, and Immunity. 20: 61
Saurer TB, Carrigan KA, Ijames SG, et al. (2005) #121 A role for neuropeptide Y in the suppression of natural killer cell activity by morphine Brain, Behavior, and Immunity. 19: e63
Carrigan KA, Saurer TB, Ijames SG, et al. (2004) Buprenorphine produces naltrexone reversible alterations of immune status. International Immunopharmacology. 4: 419-28
Saurer TB, Carrigan KA, Ijames SG, et al. (2004) Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. Journal of Neuroimmunology. 148: 54-62
See more...